Happy New Year! Here are emDOCs' top 10 list of most viewed posts of 2023.

Thank you for everything you do! We bring you the top posts from this last year.

The Policy Playbook is back with COVID-19.

This year has been full of great #FOAMed, and the emDOCs team is incredibly grateful for our readers, our editorial team, and our awesome authors. You and your amazing support keep us going. Here is our list of top posts from 2019. Stay tuned for an exciting 2020, and thanks again for your support!

The Institute of Medicine’s 1999 report “To Err is Human: Building a Safer Health System” drew attention to medical errors and the need for improving quality and safety in medicine. Since then, a body of literature has emerged suggesting that transparency around adverse events and medical err...

Please see prior post here: http://www.emdocs.net/reversal-of-anticoagulation/ On October 16, 2015 the FDA granted accelerated approval of idarucizumab (Praxbind), a novel reversal agent of the direct thrombin inhibitor Dabigatran (Pradaxa), for utilization in life-threatening bleeding emergencies.1

I HAVE BECOME INFATUATED WITH THE PATIENT CARE EXPERIENCE. I believe the term “patient care experience” is a more inclusive term that describes our technical expertise while also including everything else, such as communication, department ambience, throughput, and the behavior of everyone a patient comes into contact with while in the department.

"As one develops a skill set, FOAM becomes a more valued tool for fine-tuning your already engrained knowledge"Coverage of the FOAMed workshop at CORD 2014 from Adaira Landry, MD (@allarounddoc), with a primer on how to get involved in the social media and medical education movement.